STAT3 and colorectal carcinoma: JAK2 is a well-known upstream regulator of STAT3 activation in cancer cells (Bowman et al., 2000), and the JAK2/STAT3 pathway has been shown to alter the expression of key oncogenes and tumor suppressor genes to enhance the growth, survival, and metastasis of CRC cells (Xiong et al., 2008).